Source: WSJ
AstraZenecaAZN1.24%PLC said Saturday clinical trials for its experimental coronavirus vaccine have resumed in the U.K. after regulators concluded it was safe to do so, followinga pause in studies globallyafter a person who received the vaccine hadan unexplained illness.
Trials in other countries, including the U.S., remain paused while AstraZeneca works with national health authorities, the company said.
AstraZeneca said Tuesday it paused trials globally of a vaccine it licensed from the University of Oxford after a vaccinated woman in the U.K. experienced the unexplained illness, which a U.S. official described as a spinal cord problem.
The best of the Muslim Times’ collection for war against Covid 19:
In this…
View original post 203 more words
